FR2655853B1 - Procede de culture intensive, in vitro, de souches de babesia divergens, procede de preparation d'exoantigenes et vaccin contenant ces antigenes. - Google Patents

Procede de culture intensive, in vitro, de souches de babesia divergens, procede de preparation d'exoantigenes et vaccin contenant ces antigenes.

Info

Publication number
FR2655853B1
FR2655853B1 FR898916890A FR8916890A FR2655853B1 FR 2655853 B1 FR2655853 B1 FR 2655853B1 FR 898916890 A FR898916890 A FR 898916890A FR 8916890 A FR8916890 A FR 8916890A FR 2655853 B1 FR2655853 B1 FR 2655853B1
Authority
FR
France
Prior art keywords
exoantigens
antigens
strains
vitro
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR898916890A
Other languages
English (en)
Other versions
FR2655853A1 (fr
Inventor
Schrevel Joseph
Gorenflot Andre
Precigout Eric
Marchand Alain
Brasseur Philippe
L Hostis Monique
Rigomier Daniel
Valentin Alexis
Francois
Marie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR898916890A priority Critical patent/FR2655853B1/fr
Priority to ZA9010116A priority patent/ZA9010116B/xx
Priority to PT96273A priority patent/PT96273A/pt
Priority to EP91901827A priority patent/EP0460177A1/fr
Priority to IE463890A priority patent/IE904638A1/en
Priority to US07/752,625 priority patent/US5290688A/en
Priority to AU70547/91A priority patent/AU641723B2/en
Priority to PCT/FR1990/000934 priority patent/WO1991008771A2/fr
Publication of FR2655853A1 publication Critical patent/FR2655853A1/fr
Application granted granted Critical
Publication of FR2655853B1 publication Critical patent/FR2655853B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/947—Microorganisms using protozoa

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR898916890A 1989-12-20 1989-12-20 Procede de culture intensive, in vitro, de souches de babesia divergens, procede de preparation d'exoantigenes et vaccin contenant ces antigenes. Expired - Fee Related FR2655853B1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR898916890A FR2655853B1 (fr) 1989-12-20 1989-12-20 Procede de culture intensive, in vitro, de souches de babesia divergens, procede de preparation d'exoantigenes et vaccin contenant ces antigenes.
ZA9010116A ZA9010116B (en) 1989-12-20 1990-12-17 Process for the intensive in vitro culture of strains of babesia divergens,process for preparing exoantigens and vaccine containing these antigens
PT96273A PT96273A (pt) 1989-12-20 1990-12-19 Processo de cultura intensiva,"in vitro", de estirpes de babesia divergens,processo para a preparacao de exoantigenios e vacina contendo estes antigenios
IE463890A IE904638A1 (en) 1989-12-20 1990-12-20 Process for the intensive in vitro culture of strains of¹babesia divergens, process for preparing exoantigens and¹vaccine containing these antigens
EP91901827A EP0460177A1 (fr) 1989-12-20 1990-12-20 Procede de culture intensive, in vitro, de souches de babesia divergens, procede de preparation d'exoantigenes et vaccin contenant ces antigenes
US07/752,625 US5290688A (en) 1989-12-20 1990-12-20 Method for intensive, in vitro culture of Babesia divergens strains
AU70547/91A AU641723B2 (en) 1989-12-20 1990-12-20 Method for intensive, in vitro culture of babesia divergens strains, method for preparing exoantigens and vaccines containing these antigens
PCT/FR1990/000934 WO1991008771A2 (fr) 1989-12-20 1990-12-20 Procede de culture intensive, in vitro, de souches de babesia divergens, procede de preparation d'exoantigenes et vaccin contenant ces antigenes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR898916890A FR2655853B1 (fr) 1989-12-20 1989-12-20 Procede de culture intensive, in vitro, de souches de babesia divergens, procede de preparation d'exoantigenes et vaccin contenant ces antigenes.

Publications (2)

Publication Number Publication Date
FR2655853A1 FR2655853A1 (fr) 1991-06-21
FR2655853B1 true FR2655853B1 (fr) 1994-06-10

Family

ID=9388758

Family Applications (1)

Application Number Title Priority Date Filing Date
FR898916890A Expired - Fee Related FR2655853B1 (fr) 1989-12-20 1989-12-20 Procede de culture intensive, in vitro, de souches de babesia divergens, procede de preparation d'exoantigenes et vaccin contenant ces antigenes.

Country Status (8)

Country Link
US (1) US5290688A (fr)
EP (1) EP0460177A1 (fr)
AU (1) AU641723B2 (fr)
FR (1) FR2655853B1 (fr)
IE (1) IE904638A1 (fr)
PT (1) PT96273A (fr)
WO (1) WO1991008771A2 (fr)
ZA (1) ZA9010116B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2724392B1 (fr) * 1994-09-08 1996-12-13 Virbac Lab Procedes de culture, d'attenuation de la virulence et de clonage in vitro de parasites du genre babesia et leurs applications

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4055466A (en) * 1973-07-09 1977-10-25 Johnson & Johnson Culture medium for tissue culture techniques
US4596707A (en) * 1979-04-30 1986-06-24 University Of Illinois Foundation Babesia parasite antigen useful in vaccine and diagnostic reagent
GB2062463B (en) * 1979-11-06 1983-11-23 Commw Scient Ind Res Org Babesiosis vaccine
US4767622A (en) * 1983-08-19 1988-08-30 University Of Illinois Method and materials for development of immunological responses protective against malarial infection
FR2589063B1 (fr) * 1985-10-24 1988-08-26 Rhone Merieux Procede de culture de babesia canis, application a la preparation d'antigenes et de vaccins, et antigenes et vaccins contre la piroplasmose
GB8630851D0 (en) * 1986-12-24 1987-02-04 Department Of Agriculture For Babesia divergens antigen & vaccine
ZA902546B (en) * 1989-04-04 1991-04-24 Univ Florida Novel proteins and cloned genes for diagnosis and prophylaxis of babesiosis

Also Published As

Publication number Publication date
ZA9010116B (en) 1991-09-25
EP0460177A1 (fr) 1991-12-11
US5290688A (en) 1994-03-01
PT96273A (pt) 1991-09-30
AU641723B2 (en) 1993-09-30
WO1991008771A3 (fr) 1991-08-08
WO1991008771A2 (fr) 1991-06-27
IE904638A1 (en) 1991-07-17
FR2655853A1 (fr) 1991-06-21
AU7054791A (en) 1991-07-18

Similar Documents

Publication Publication Date Title
AR240251A1 (es) Metodo para preparar una composicion para tratamiento de infecciones virales y un metodo para sintetizar 3' azido 2', 3' dideoxiuridina destinada a la preparacion de dicha composicion.
ZA894728B (en) A new pharmaceutical formulation as well as a process for its preparation
MA20878A1 (fr) Derives d'indolizine, leur procede de preparation ainsi que les compositions en contenant
MA22894A1 (fr) Procede de preparation d'un vaccin.
IT8721005A0 (it) Metodo per la preservazione difogli trapiantabili di epitelio coltivato in vitro vitale.
FR2628324B1 (fr) Compositions pharmaceutiques antivirales et immunostimulantes et procede pour les preparer
FR2599626B1 (fr) Antigene du flavivirus, procede pour sa production et vaccin le contenant
AU1347688A (en) Viral antigen, process for its production, and application in diagnosis and therapy (vaccine)
FI870808A (fi) 9-alfa, 11-beta-substituerade och 11-beta-substituerade estraner.
FR2655977B1 (fr) Procede d'elaboration d'un materiau composite ceramique fibres-matrice, et materiau composite obtenu par ce procede.
AU2192588A (en) Immunogenic composites capable of selectively inducing antibody production, pharmaceutical compositions employing the same and method of selectively inducing antibody production
FR2655853B1 (fr) Procede de culture intensive, in vitro, de souches de babesia divergens, procede de preparation d'exoantigenes et vaccin contenant ces antigenes.
MA22097A1 (fr) Procede de preparation de polypeptide et procede de fabrication d'un vaccin contre le paludisme .
AU3018289A (en) Anaplasma marginale antigen, antigen compositions, vaccine and process for the production of said antigen, antigen compositions, and vaccine
IT1239447B (it) Sistema e dispositivi per la preparazione di prodotti di ricupero da rifiuti e simili in particolare di ammendante agricolo arricchito.
GR3034886T3 (en) Substituted benzenesulfonylureas and -thioureas, process for their preparation and their use in the production of pharmaceutical preparations as well as pharmaceutical preparations containing them
PT87301A (pt) Process for the preparation of 1,3-dioxanes by products and of pharmaceutical compounds containing them
FR2589063B1 (fr) Procede de culture de babesia canis, application a la preparation d'antigenes et de vaccins, et antigenes et vaccins contre la piroplasmose
FR2608926B1 (fr) Antigene de babesia divergens, procede pour le produire et vaccin le contenant
FR2499410B1 (fr) Vaccin contre l'avortement enzootique chez les brebis et son procede de preparation
PT77767B (fr) Procede de preparation de 3',5'-diarabinosides et de compositi-ons pharmaceutiques les contenant
FR2612519B1 (fr) Nouvelles fractions peptidiques inductrices d'anticorps protecteurs contre le virus de la leucemie bovine, procede pour l'obtention de telles fractions, leurs sequences codantes et vaccins realises a partir de ces fractions
FR2731355B1 (fr) Nouveaux immunogenes, nouveaux anticorps, procede de preparation et compositions pharmaceutiques les renfermant
FR2601250B1 (fr) Procede de preparation de fractions antigeniques exocellulaires de bordetella pertussis et vaccin contre la coqueluche contenant de telles fractions.
AU5217890A (en) Monoclonal antibodies in vaccine formulations

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse